Mirae Asset Global ETFs Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	52,360 +3,133	+6%	+$65.2K	﹤0.01%	1575
2026 Q1	$1.14M	Buy	49,227 +182	+0.4%	+$3.96K	﹤0.01%	1458
2025 Q4	$1.03M	Buy	49,045 +2,204	+5%	+$38.5K	﹤0.01%	1502
2025 Q3	$722K	Sell	46,841 -6,004	-11%	-$78.6K	﹤0.01%	1679
2025 Q2	$493K	Sell	52,845 -3,997	-7%	-$44K	﹤0.01%	1826
2025 Q1	$705K	Buy	56,842 +3,094	+6%	+$43.6K	﹤0.01%	1672
2024 Q4	$706K	Buy	53,748 +1,811	+3%	+$31K	﹤0.01%	1737
2024 Q3	$997K	Buy	51,937 +4,564	+10%	+$94.3K	﹤0.01%	1542
2024 Q2	$971K	Buy	+47,373	New	+$991K	﹤0.01%	1470

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SNDX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Syndax Pharmaceuticals (SNDX) stake by 6.4% in Q2 2026, buying an estimated $65.2K and bringing the position to 52,360 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Mirae Asset Global ETFs Holdings first reported a position in SNDX in Q2 2024 and has held it in 9 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 52,360 shares of Syndax Pharmaceuticals worth $1.14M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 3,133 Syndax Pharmaceuticals shares in Q2 2026, an estimated $65.2K.
Syndax Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1575 holding.
Mirae Asset Global ETFs Holdings first reported a position in Syndax Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.